| |
4-hour HD, n = 40 |
6-hour HD, n = 37 |
p value |
| Epoetin dose (U/week) |
5682.9 ± 3863.3 |
3111.8 ± 2360.8 |
<0.0007 |
| Kt/V |
1.4 ± 0.2 |
1.4 ± 0.2 |
NS |
| Membrane surface area (m2) |
1.6 ± 0.4 |
1.1 ± 0.2 |
<0.0001 |
| Quantity of blood flow (mL/minute) |
199.1 ± 23.3 |
188.4 ± 20.6 |
NS |
| Quantity of dialysate flow (mL/minute) |
485.6 ± 13.5 |
500.0 ± 0.0 |
NS |
| Age (years) |
65.4 ± 11.7 |
67.2 ± 9.2 |
NS |
| Length of treatment (years) |
5.3 ± 4.2 |
5.0 ± 4.2 |
NS |
| Male (%) |
62.5 |
64.9 |
NS |
| Body mass index |
21.4 ± 3.7 |
21.5 ± 3.1 |
NS |
| Height (cm) |
158.6 ± 8.5 |
161.1 ± 10.2 |
NS |
| Dry weight (kg) |
54.0 ± 10.8 |
55.8 ± 10.2 |
NS |
| Hemoglobin (g/dL) |
11.1 ± 1.1 |
11.0 ± 0.9 |
NS |
| Ferritin (ng/mL) |
175.9 ± 118.7 |
172.0 ± 88.6 |
NS |
| Albumin (g/dL) |
3.7 ± 0.4 |
3.8 ± 0.4 |
NS |
| C-reactive protein (mg/dL) |
0.5 ± 0.7 |
0.4 ± 0.5 |
NS |
| Intact parathyroid hormone (ng/mL) |
137.1 ± 108.8 |
114.3 ± 122.3 |
NS |
|
